Skip to main content

MediWound Ltd.

MDWD
Exchange
Nasdaq
Industry
Medicinal Chemicals & Botanical Products
SEC CIK
0001593984

In the last 90 days, MediWound Ltd. insiders filed 1 open-market purchase and 2 sales; 78 institutions reported holding it in 13F filings for Q2 2026, worth $85.5M in total; ARK Invest is the only superinvestor holding it.

Q3 2021 vs. Q2 2021

How the institutions holding MediWound Ltd. changed between Q2 2021 and Q3 2021.

All holders in Q3 2021All holders in Q2 2021

13F holders of MDWD: Q2 2021 compared with Q3 2021
MeasureQ2 2021Q3 2021Change
Holders2426+2
Shares3.56M3.54M−18.4K (−0.5%)
Value$13.6M$11.8M−$1.81M (−13.3%)

New holders (7)

Institutions that held MediWound Ltd. at the end of Q3 2021 but not at the end of Q2 2021.

Institutions new to MDWD in Q3 2021
InstitutionSharesValue% of portfolio
ARK Investment Management LLCSuperinvestorARK Invest764,876$2.56M0.01%
Bokf, NA363,002$1.21M0.02%
Goldman Sachs Group Inc14,504$48.0K0.00%
Jane Street Group, LLC11,522$38.0K0.00%
Tower Research Capital LLC (TRC)5,533$18.0K0.00%
Koshinski Asset Management, Inc.2,275$7.60K0.00%
Barclays PLC1$00.00%

Sold out (5)

Institutions that held MediWound Ltd. at the end of Q2 2021 and filed for Q3 2021 without it.

Institutions that sold out of MDWD in Q3 2021
InstitutionShares, Q2 2021Value, Q2 2021
Wellington Management Group LLP192,120$736.0K
Toroso Investments, LLC17,149$66.0K
Squarepoint Ops LLC17,009$65.0K
UBS Group AG2,727$10.0K
Salem Investment Counselors Inc5$0